Published in Mov Disord on August 01, 2006
Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology (2013) 3.56
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord (2013) 2.01
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol (2013) 1.83
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat Rev Neurosci (2013) 1.82
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One (2010) 1.72
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord (2012) 1.69
Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.59
Longitudinal study of normal cognition in Parkinson disease. Neurology (2015) 1.59
Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol (2007) 1.42
Non-motor features of Parkinson disease. Nat Rev Neurosci (2017) 1.42
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. Br J Clin Pharmacol (2012) 1.39
Epidemiology of Parkinson's disease. J Neurol (2008) 1.38
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab (2012) 1.32
Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. Brain (2012) 1.31
White matter lesions in Parkinson disease. Nat Rev Neurol (2011) 1.30
Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord (2009) 1.19
Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease. Br J Clin Pharmacol (2012) 1.17
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Mov Disord (2015) 1.15
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease. Mov Disord (2012) 1.15
Parkinson's disease dementia: a neural networks perspective. Brain (2015) 1.10
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One (2013) 1.09
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol (2009) 1.05
What can biomarkers tell us about cognition in Parkinson's disease? Mov Disord (2014) 1.03
Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology (2014) 1.00
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry (2010) 0.98
Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord (2013) 0.96
Relation of Parkinson's disease subtypes to visual activities of daily living. J Int Neuropsychol Soc (2011) 0.92
Parkinson's disease cognitive network correlates with caudate dopamine. Neuroimage (2013) 0.91
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Parkinsons Dis (2013) 0.91
Tai Chi Exercise to Improve Non-Motor Symptoms of Parkinson's Disease. J Yoga Phys Ther (2013) 0.90
Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord (2014) 0.89
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. Parkinsonism Relat Disord (2014) 0.88
Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease. Front Aging Neurosci (2014) 0.87
FDG PET in the Evaluation of Parkinson's Disease. PET Clin (2010) 0.87
Differential susceptibility to motor impulsivity among functional subtypes of Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 0.86
The impact of sleep quality on cognitive functioning in Parkinson's disease. J Int Neuropsychol Soc (2011) 0.86
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study. Acta Neuropathol (2016) 0.86
Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease. Parkinsonism Relat Disord (2010) 0.85
Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. Eur J Nucl Med Mol Imaging (2014) 0.84
Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort. J Neurol (2009) 0.84
Poor Gait Performance and Prediction of Dementia: Results From a Meta-Analysis. J Am Med Dir Assoc (2016) 0.84
Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease. Parkinsonism Relat Disord (2013) 0.84
Sleep quality in Parkinson disease: an examination of clinical variables. Cogn Behav Neurol (2011) 0.83
Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson's disease. Arch Phys Med Rehabil (2013) 0.82
Tracking Parkinson's: Study Design and Baseline Patient Data. J Parkinsons Dis (2015) 0.81
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease. Arch Med Sci (2011) 0.80
Cues and Attention in Parkinsonian Gait: Potential Mechanisms and Future Directions. Front Neurol (2015) 0.80
Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism. J Neurol (2011) 0.79
What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic? Exp Neurobiol (2014) 0.79
Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease. PLoS One (2015) 0.79
Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study. Eur J Nucl Med Mol Imaging (2010) 0.78
Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease. Front Neurol (2015) 0.78
Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. J Gerontol A Biol Sci Med Sci (2014) 0.78
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Acad Radiol (2016) 0.78
Predictors of cognitive decline in the early stages of Parkinson's disease: a brief cognitive assessment longitudinal study. Parkinsons Dis (2013) 0.78
The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group. J Clin Neurol (2016) 0.78
Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. US Neurol (2011) 0.78
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease. Mov Disord (2016) 0.77
GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease. PLoS One (2016) 0.77
Meta-analysis of risk factors for Parkinson's disease dementia. Transl Neurodegener (2016) 0.77
How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study. J Neurol (2009) 0.77
Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Mov Disord (2011) 0.76
The effect of Parkinson's disease subgroups on verbal and nonverbal fluency. J Clin Exp Neuropsychol (2014) 0.76
Neural and behavioral substrates of subtypes of Parkinson's disease. Front Syst Neurosci (2013) 0.76
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease. J Neurol (2014) 0.76
Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers. BMC Neurosci (2016) 0.76
Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study. Biomed Res Int (2013) 0.76
Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia. PLoS One (2013) 0.75
Is PIGD a legitimate motor subtype in Parkinson disease? Ann Clin Transl Neurol (2016) 0.75
Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters. Sci Rep (2017) 0.75
Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study. PLoS One (2016) 0.75
Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients. Aging Dis (2016) 0.75
Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis. PLoS One (2016) 0.75
Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disorders. Medicine (Baltimore) (2016) 0.75
Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Ann Clin Transl Neurol (2016) 0.75
Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease. J Mov Disord (2016) 0.75
Neuropsychiatric symptoms in untreated Parkinson's disease. Neuropsychiatr Dis Treat (2017) 0.75
Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study. J Neurol (2017) 0.75
Baseline motor findings and Parkinson disease prognostic subtypes. Neurology (2017) 0.75
Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease. J Neurol (2015) 0.75
White matter microstructure damage in tremor-dominant Parkinson's disease patients. Neuroradiology (2017) 0.75
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Alzheimer's disease. Lancet (2011) 5.35
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol (2013) 3.70
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology (2007) 2.32
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21
Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol (2013) 2.19
Endovascular acute stroke treatment performed by vascular interventional radiologists: is it safe and efficacious? Cardiovasc Intervent Radiol (2012) 2.06
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Paternity following treatment for testicular cancer. J Natl Cancer Inst (2005) 1.87
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86
Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord (2013) 1.74
Post-traumatic stress reactions in survivors of the 2011 massacre on Utøya Island, Norway. Br J Psychiatry (2013) 1.73
Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord (2008) 1.71
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66
Growth of untreated vestibular schwannoma: a prospective study. J Neurosurg (2012) 1.66
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54
Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53
Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer (2009) 1.52
Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey. Alzheimer Dis Assoc Disord (2003) 1.52
Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord (2003) 1.51
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50
Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion (2009) 1.50
Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia (2011) 1.50
Factors complicating interpretation of capnography during advanced life support in cardiac arrest--a clinical retrospective study in 575 patients. Resuscitation (2012) 1.50
The other side of the coin: perceived positive effects of illness in women following acute myocardial infarction. Eur J Cardiovasc Nurs (2007) 1.48
Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry (2008) 1.47
The rate of cognitive decline in Parkinson disease. Arch Neurol (2004) 1.44
Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol (2010) 1.43
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord (2013) 1.41
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Epidemiology of Parkinson's disease. J Neurol (2008) 1.38
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord (2008) 1.33
Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 1.32
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol Aging (2012) 1.31
Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry (2004) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
The coping styles of adolescents with type 1 diabetes are associated with degree of metabolic control. Diabetes Care (2004) 1.28
Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28
The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25
Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med (2007) 1.24
The day Norway cried: Proximity and distress in Norwegian citizens following the 22nd July 2011 terrorist attacks in Oslo and on Utøya Island. Eur J Psychotraumatol (2012) 1.24
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol (2008) 1.21
Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20
Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19
Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry (2009) 1.19
Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry (2007) 1.17
Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011) 1.17
Reduced white matter connectivity in the corpus callosum of children with Tourette syndrome. J Child Psychol Psychiatry (2006) 1.16
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Curr Med Res Opin (2003) 1.16
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery (2005) 1.16
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry (2010) 1.16
Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud (2011) 1.16
Associations between sleep problems and attentional and behavioral functioning in children with anxiety disorders and ADHD. Behav Sleep Med (2013) 1.15
The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psychiatry (2002) 1.15
Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care (2007) 1.13
Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis (2010) 1.12
Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med (2007) 1.10
Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiol Aging (2011) 1.09
Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol (2004) 1.09
Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc (2010) 1.09
Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08